Roxadustat Versus ESA Therapy for Sustained Hemoglobin Response in ESA-Hyporesponsive Hemodialysis Patients
{{output}}
Background: In Erythropoiesis-Stimulating Agent (ESA)-hyporesponsive hemodialysis patients, hemoglobin (Hb) change from baseline may not fully capture durable treatment response. This secondary analysis evaluated sustained Hb ≥ ... ...
